Impact of fetal treatments for congenital diaphragmatic hernia on lung development

Mar Janna Dahl, Anna Lavizzari, Jonathan W. Davis, Peter B. Noble, Raffaele Dellacà, J. Jane Pillow

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


The extent of lung hypoplasia impacts the survival and severity of morbidities associated with congenital diaphragmatic hernia (CDH). The alveoli of CDH infants and in experimental models of CDH have thickened septa with fewer type II pneumocytes and capillaries. Fetal treatments of CDH-risk preterm birth. Therefore, treatments must aim to balance the need for increased gas exchange surface area with the restoration of pulmonary epithelial type II cells and the long-term respiratory and neurodevelopmental consequences of pre-maturity. Achievement of sufficient lung development in utero for successful postnatal transition requires adequate intra-thoracic space for lung growth, maintenance of sufficient volume and appropriate composition of fetal lung fluid, regular fetal breathing movements, appropriate gas exchange area, and ample surfactant production. The review aims to examine the rationale for cur-rent and future therapeutic strategies to improve postnatal outcomes of infants with CDH.
Original languageEnglish
Number of pages16
JournalThe Anatomical Record
Publication statusE-pub ahead of print - 5 Sept 2022


Dive into the research topics of 'Impact of fetal treatments for congenital diaphragmatic hernia on lung development'. Together they form a unique fingerprint.

Cite this